Chinmay Jani, MD, discusses the rate of inclusion of patient-reported outcome end points in clinical trials of patients with lung cancer.
Chinmay Jani, MD
Advertisement
Chinmay Jani, MD, is the chief fellow of hematology and oncology at the University of Miami Sylvester Comprehensive Cancer Center.
Articles by Chinmay Jani, MD
Advertisement
Latest Updated Articles
Dr Jani on the Inclusion of PRO End Points in Lung Cancer Clinical TrialsPublished: July 1st 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
2
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis
5